Year |
Citation |
Score |
2021 |
Kolos JM, Pomplun S, Jung S, Rieß B, Purder PL, Voll AM, Merz S, Gnatzy M, Geiger TM, Quist-Løkken I, Jatzlau J, Knaus P, Holien T, Bracher A, Meyners C, et al. Picomolar FKBP inhibitors enabled by a single water-displacing methyl group in bicyclic [4.3.1] aza-amides. Chemical Science. 12: 14758-14765. PMID 34820091 DOI: 10.1039/d1sc04638a |
0.642 |
|
2021 |
Pomplun S, Jbara M, Schissel CK, Wilson Hawken S, Boija A, Li C, Klein I, Pentelute BL. Parallel Automated Flow Synthesis of Covalent Protein Complexes That Can Inhibit MYC-Driven Transcription. Acs Central Science. 7: 1408-1418. PMID 34471684 DOI: 10.1021/acscentsci.1c00663 |
0.664 |
|
2021 |
Jbara M, Pomplun S, Schissel CK, Hawken SW, Boija A, Klein I, Rodriguez J, Buchwald SL, Pentelute BL. Engineering Bioactive Dimeric Transcription Factor Analogs via Palladium Rebound Reagents. Journal of the American Chemical Society. PMID 34289685 DOI: 10.1021/jacs.1c05666 |
0.677 |
|
2021 |
Pomplun S, Jbara M, Quartararo AJ, Zhang G, Brown JS, Lee YC, Ye X, Hanna S, Pentelute BL. Discovery of High-Affinity Peptide Binders for the SARS-CoV-2 Spike Protein. Acs Central Science. 7: 156-163. PMID 33527085 DOI: 10.1021/acscentsci.0c01309 |
0.71 |
|
2021 |
Pomplun S. Targeting the SARS-CoV-2-spike protein: from antibodies to miniproteins and peptides Rsc Medicinal Chemistry. 12: 197-202. DOI: 10.1039/d0md00385a |
0.421 |
|
2020 |
Pomplun S. Targeting the SARS-CoV-2-spike protein: from antibodies to miniproteins and peptides. Rsc Medicinal Chemistry. 12: 197-202. PMID 34041482 DOI: 10.1039/d0md00385a |
0.47 |
|
2020 |
Pomplun S, Gates ZP, Zhang G, Quartararo AJ, Pentelute BL. Discovery of Nucleic Acid Binding Molecules from Combinatorial Biohybrid Nucleobase Peptide Libraries. Journal of the American Chemical Society. 142: 19642-19651. PMID 33166454 DOI: 10.1021/jacs.0c08964 |
0.681 |
|
2020 |
Pomplun S, Shugrue CR, Schmitt AM, Schissel CK, Farquhar CE, Pentelute BL. Secondary Amino Alcohols: Traceless Cleavable Linkers for Use in Affinity Capture and Release. Angewandte Chemie (International Ed. in English). 59: 11566-11572. PMID 32227406 DOI: 10.1002/Anie.202003478 |
0.704 |
|
2019 |
Pomplun S, Mohamed MY, Oelschlaegel T, Wellner C, Bergmann F. Efficient Pictet Spengler Bioconjugation with N-Substituted Pyrrolyl Alanine Derivatives. Angewandte Chemie (International Ed. in English). PMID 30653800 DOI: 10.1002/anie.201814200 |
0.292 |
|
2018 |
Pomplun S, Sippel C, Hähle A, Tay D, Shima K, Klages A, Ünal CM, Rieß B, Toh HT, Hansen G, Yoon HS, Bracher A, Preiser PR, Rupp J, Steinert M, et al. Chemogenomic profiling of human and microbial FK506-binding proteins. Journal of Medicinal Chemistry. PMID 29578710 DOI: 10.1021/Acs.Jmedchem.8B00137 |
0.672 |
|
2015 |
Feng X, Pomplun S, Hausch F. Recent Progress in FKBP Ligand Development. Current Molecular Pharmacology. 9: 27-36. PMID 25986570 DOI: 10.2174/1874467208666150519113313 |
0.641 |
|
2015 |
Pomplun S, Wang Y, Kirschner A, Kozany C, Bracher A, Hausch F. Rational design and asymmetric synthesis of potent and neurotrophic ligands for FK506-binding proteins (FKBPs). Angewandte Chemie (International Ed. in English). 54: 345-8. PMID 25412894 DOI: 10.1002/Anie.201408776 |
0.7 |
|
2014 |
Cuboni S, Devigny C, Hoogeland B, Strasser A, Pomplun S, Hauger B, Höfner G, Wanner KT, Eder M, Buschauer A, Holsboer F, Hausch F. Loratadine and analogues: discovery and preliminary structure-activity relationship of inhibitors of the amino acid transporter B(0)AT2. Journal of Medicinal Chemistry. 57: 9473-9. PMID 25318072 DOI: 10.1021/Jm501086V |
0.6 |
|
2014 |
Pomplun S, Wang Y, Kirschner A, Kozany C, Bracher A, Hausch F. Rationales Design und asymmetrische Synthese potenter neuritotropher Liganden für FK506-bindende Proteine (FKBPs) Angewandte Chemie. 127: 352-355. DOI: 10.1002/Ange.201408776 |
0.612 |
|
Show low-probability matches. |